August 09, 2018
MARLBOROUGH, Mass., July 31, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that Chief Financial Officer (CFO) Bob McMahon is leaving the Company to become the CFO of Agilent (NYSE: A).
Company veteran Karleen Oberton, who currently serves as Hologic's Chief Accounting Officer, has been promoted to CFO, effective tomorrow.
"Bob has made tremendous contributions to Hologic over the last four years, and we wish him all the best in his new role," said Steve MacMillan, the Company's Chairman, President and Chief Executive Officer. "At the same time, we are excited to promote Karleen to CFO. She has a deep knowledge of our business and people based on more than 12 years of experience at the Company, and has been a great partner to our divisions. She has been instrumental in our efforts both to drive profitable growth, and to strengthen our balance sheet and cash flows."
Ms. Oberton joined Hologic in 2006 as Corporate Controller, and was promoted to Chief Accounting Officer in 2015. In this role, she was responsible for the global finance organization, including controllership functions, financial planning and analysis, and shared services. She was appointed to the Company's new Global Leadership Team in 2017. Before joining Hologic, she served as Senior Corporate Controller of Immunogen from 2004 to 2006. Prior to that, she was a Senior Audit Manager in Ernst & Young's life science practice and in Arthur Andersen's high technology practice. She was an active Certified Public Accountant for more than 18 years, and holds a BS in Business Administration from Merrimack College, where she is a member of the Leadership Council.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.
SOURCE Hologic, Inc.